Sale to GHO Capital
Baird served as exclusive financial advisor to Validant on this transaction
AboutKinsale Holdings Inc. (d.b.a. as Validant, or the “Company”), was recently acquired by GHO Capital (“GHO”). Terms of the transaction were not disclosed.
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the pharma and med tech sectors.
Founded in 2005, Validant has established itself as a leader in its specialist field, providing tailored expert teams to solve critical customer issues. With an unparalleled expert consultant network, Validant focuses on being highly responsive to unique and complex customer needs. The Company benefits from an exceptional track record, having advised 20 of the top 30 Global Pharmaceutical firms, 25 of the top 30 Medical Device firms, and 7 of the top 10 Biotechnology firms globally. Validant operates in a high growth market, driven by continued focus on patient safety and product quality from manufacturers and global regulatory bodies alike, as well the increased penetration of specialist outsourced providers serving the industry. The Company is achieving rapid international growth, supporting customers on five continents as they navigate across multiple markets in an increasingly complex regulatory environment. Validant is headquartered in San Francisco, California.
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. GHO applies global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value. GHO’s proven investment track record reflects the unrivalled depth of its industry expertise and network. GHO partners with strong management teams to unlock value in a global system that demands the provision of better, faster, cheaper healthcare. GHO is headquartered in London, the United Kingdom.
CONTACT US TO LEARN MORE
- December 2018
- Target Location
- North America
- Acquiror Location